Medjet aims to offer alternative to laser in vision correction
This article was originally published in Clinica
Executive Summary
With its waterjet keratome, Medjet is hoping to market a device which will be a serious competitor to lasers in the correction of vision deficiencies. The development-stage company, based in Edison, New Jersey, intends to seek US FDA approval for hydro-therapeutic keratoplasty first, followed by a submission for hydro-refractive keratoplasty. In its prospectus for a recent public offering, the company considers that the device will only have to pass a 510(k) approval for both procedures.